- US12152076utility2024Bispecific and Monospecific Antibodies Using Novel Anti-pd-1 Sequences0 cites
- US12139525utility2024Targeted Heterodimeric Fc Fusion Proteins Containing IL-15 Il-15alpha and Antigen Binding Domains0 cites
- US12129309utility2024Heterodimeric Antibodies That Bind CD3 and CD380 cites
- US12054545utility2024Heterodimeric Antibodies That Bind Somatostatin Receptor 20 cites
- US12006345utility2024Untargeted and Targeted IL-10 Fc-fusion Proteins0 cites
- US11987636utility2024Dosing of a Bispecific Antibody That Binds CD20 and CD30 cites
- US11981717utility2024Engineered IL-2 Fc Fusion Proteins0 cites
- US11945880utility2024Heterodimeric Antibodies That Bind CD3 and Tumor Antigens0 cites
- US11932675utility2024PD-1 Targeted Il-15/il-15rα Fc Fusion Proteins with Improved Properties0 cites
- US11932685utility2024Fc Variants with Altered Binding to Fcrn0 cites
- US11919956utility2024Heterodimeric Antibodies That Bind Prostate Specific Membrane Antigen (PSMA) and CD30 cites
- US11919958utility2024Anti-cd28 Compositions0 cites
- US11859011utility2024Heterodimeric Antibodies That Bind CD3 and Tumor Antigens0 cites
- US11859012utility2024Heterodimeric Antibodies That Bind CD3 and GPC30 cites
- US11851466utility2023Targeted IL-12 Heterodimeric Fc-fusion Proteins0 cites
- US11840579utility2023Bispecific Antibodies That Bind to CD38 and CD30 cites
- US11820830utility2023Optimized Fc Variants0 cites
- US11814423utility2023Heterodimeric Proteins0 cites
- US11739144utility2023Heterodimeric Antibodies That Bind CD3 and CLDN60 cites
- US11718667utility2023Optimized Antibody Variable Regions0 cites